VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
BMC cancer
Year: 2014, Jahrgang: 14 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-14-476 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-14-476
|
| Verfasserangaben: | Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, Janis Kany, Claudia Pauligk, Kristina Steinmetz, Arno Schad, Ralf Hofheinz, Harald Schmalenberg, Nils Homann, Peter Robert Galle and Markus Moehler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1523603151 | ||
| 003 | DE-627 | ||
| 005 | 20220812132843.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 151222s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2407-14-476 |2 doi | |
| 035 | |a (DE-627)1523603151 | ||
| 035 | |a (DE-576)453603157 | ||
| 035 | |a (DE-599)BSZ453603157 | ||
| 035 | |a (OCoLC)1340895952 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Thomaidis, Thomas |d 1977- |e VerfasserIn |0 (DE-588)131923528 |0 (DE-627)516082434 |0 (DE-576)298839393 |4 aut | |
| 245 | 1 | 0 | |a VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer |b a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) |c Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, Janis Kany, Claudia Pauligk, Kristina Steinmetz, Arno Schad, Ralf Hofheinz, Harald Schmalenberg, Nils Homann, Peter Robert Galle and Markus Moehler |
| 264 | 1 | |c 2014 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 22.12.2015 | ||
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 14(2014) Artikel-Nr. 476, 9 Seiten |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) |
| 773 | 1 | 8 | |g volume:14 |g year:2014 |g extent:9 |a VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/1471-2407-14-476 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20151222 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 8 | ||
| 999 | |a KXP-PPN1523603151 |e 2876616580 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, Janis Kany, Claudia Pauligk, Kristina Steinmetz, Arno Schad, Ralf Hofheinz, Harald Schmalenberg, Nils Homann, Peter Robert Galle and Markus Moehler"]},"recId":"1523603151","language":["eng"],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"326643710","physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2001 -"],"origin":[{"publisherPlace":"London ; Berlin ; Heidelberg","dateIssuedKey":"2001","publisher":"BioMed Central ; Springer","dateIssuedDisp":"2001-"}],"id":{"eki":["326643710"],"issn":["1471-2407"],"zdb":["2041352-X"]},"part":{"year":"2014","extent":"9","volume":"14","text":"14(2014) Artikel-Nr. 476, 9 Seiten"},"note":["Gesehen am 22.05.20"],"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}],"disp":"VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)BMC cancer"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"subtitle":"a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)","title_sort":"VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer","title":"VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer"}],"person":[{"display":"Thomaidis, Thomas","family":"Thomaidis","role":"aut","given":"Thomas"},{"family":"Hofheinz","role":"aut","given":"Ralf-Dieter","display":"Hofheinz, Ralf-Dieter"}],"note":["Gesehen am: 22.12.2015"],"id":{"eki":["1523603151"],"doi":["10.1186/1471-2407-14-476"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}]} | ||
| SRT | |a THOMAIDISTVEGFR3ANDC2014 | ||